131
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Enhancement in brain uptake of vitamin D3 nanoemulsion for treatment of cerebral ischemia: formulation, gamma scintigraphy and efficacy study in transient middle cerebral artery occlusion rat models

, , , , , , , , , & show all
Pages 492-501 | Received 02 Dec 2019, Accepted 22 Jul 2020, Published online: 06 Aug 2020

References

  • Abdou, E.M., et al., 2017. Brain targeting efficacy of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. International journal of pharmaceutics, 529 (1), 667–677.
  • Alexander, A., et al., 2019. Recent expansions of novel strategies towards the drug targeting into the brain. International journal of nanomedicine, 14, 5895–5909.
  • Araújo, F.A., et al., 2011. Development and characterization of parenteral nanoemulsions containing thalidomide. European journal of pharmaceutical sciences, 42 (3), 238–245.
  • Baldwin, A.S., 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual review of immunology, 14 (1), 649–681.
  • Basnyat, B., et al., 2001. Infections at high altitude. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 33 (11), 1887–1891.
  • Benjamin, E.J., et al., 2017. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation, 135 (10), e146–e603.
  • Bourganis, V., et al., 2018. Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. European journal of pharmaceutics and biopharmaceutics, 128, 337–362.
  • Brand-Williams, W., et al., 1995. Use of a free radical method to evaluate antioxidant activity. Lwt - food science and technology, 28 (1), 25–30.
  • Brea, D., et al., 2009. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia. Cerebrovascular diseases, 27 (1), 48–64.
  • Camandola, S. and Mattson, M.P., 2007. NF-kappa B as a therapeutic target in neurodegenerative diseases . Expert opinion on therapeutic targets, 11 (2), 123–132.
  • Chandra Bhatt, P., et al., 2016. Nose to brain delivery of astaxanthin-loaded solid lipid nanoparticles: fabrication, radio labeling, optimization and biological studies. RSC advances, 6 (12), 10001–10010.
  • Cohen-Lahav, M., et al., 2006. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrology dialysis transplantation, 21 (4), 889–897.
  • Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of biochemistry and biophysics, 82 (1), 70–77.
  • Garcia, J.L.A., 1996. The heart of racism. Journal of social philosophy, 27 (1), 5–46.
  • Gupta, A., et al., 2016. Effect of vitamin D and calcium supplementation on ischaemic stroke outcome: a randomized controlled open-label trial. International journal of clinical practice, 70 (9), 764–770.
  • Gupta, R., et al., 2018. Recent advances in formulation strategies for efficient delivery of vitamin D. AAPS pharmscitech, 20 (1), 11.
  • Gupta, S., et al., 2017. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats. Experimental neurology, 288, 25–37.
  • Guttoff, M., et al., 2015. Formation of vitamin D nanoemulsion-based delivery systems by spontaneous emulsification: factors affecting particle size and stability. Food chemistry, 171, 117–122.
  • Hossmann, K.A., 1994. Viability thresholds and the penumbra of focal ischemia. Annals of neurology, 36 (4), 557–565.
  • Illum, L., 2003. Nasal drug delivery—possibilities, problems and solutions. Journal of controlled release: official journal of the controlled release society, 87 (1–3), 187–198.
  • Kumar, M., et al., 2008. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. International journal of pharmaceutics, 358 (1–2), 285–291.
  • Lakhan, S.E., Kirchgessner, A., and Hofer, M., 2009. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. Journal of translational medicine, 7 (1), 97.
  • Lawrence, M.J. and Rees, G.D., 2000. Microemulsion-based media as novel drug delivery systems. Advanced drug delivery reviews, 45 (1), 89–121.
  • Liu, W., et al., 2018. The anti-inflammatory effects of vitamin D in tumorigenesis. International journal of molecular sciences, 19 (9), 2736.
  • Li, J., et al., 2018. Preparation optimization and stirage stability of nanoemulsion based lutein delivery systems. Journal of microencapsulation, 35 (6), 570–583.
  • Lowe, D.W., et al., 2017. Vitamin D improves functional outcomes in neonatal hypoxic ischemic male rats treated with N-acetylcysteine and hypothermia. Neuropharmacology, 123, 186–200.
  • Maali, A. and Mosavian, M.T.H., 2013. Preparation and application of nanoemulsions in the last decade (2000-2010). Journal of dispersion science and technology, 34 (1), 92–105.
  • Majumdar, V., et al., 2015. Vitamin D status, hypertension and ischemic stroke: a clinical perspective. Journal of human hypertension, 29 (11), 669–674.
  • Markisic, M., et al., 2017. The impact of homocysteine, vitamin B12, and vitamin D levels on functional outcome after first-ever ischaemic stroke. Biomed research international, 2017, 1–6.
  • Marklund, S. and Marklund, G., 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. European journal of biochemistry, 47 (3), 469–474.
  • Mattson, M.P. and Camandola, S., 2001. NF-kappaB in neuronal plasticity and neurodegenerative disorders. Journal of clinical investigation, 107 (3), 247–254.
  • McClements, D.J., 2012. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft matter, 8 (6), 1719–1729.
  • Md, S., et al., 2013. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. European journal of pharmaceutical sciences, 48 (3), 393–405.
  • Milanlioglu, A., et al., 2016. Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcome. Wiener klinische wochenschrift, 128 (5–6), 169–174.
  • Musa, S.H., et al., 2013. Formulation optimization of palm kernel oil esters nanoemulsion-loaded with chloramphenicol suitable for meningitis treatment. Colloids and surfaces. B, biointerfaces, 112, 113–119.
  • Ohkawa, H., et al., 1979. Assay of lipid peroxides in animals tissue by thiobarbituric acid reaction. Analytical biochemistry, 95 (2), 351–358.
  • Pangeni, R., et al., 2014. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress. Nanotechnology, 25 (48), 485102–485502.
  • Patel, R.B., et al., 2013. Formulation and evaluation of microemulsion based drug delivery system for intra nasal administration of Olanzapine. Internation journal of biomedical and pharmaceutical sciences, 7 (1), 20–27.
  • Punj, A., et al., 2017. Estimation of antioxidant levels in saliva and serum of chronic periodontitis patients with and without ischemic heart disease. International journal of dentistry, 2017, 1–9.
  • Ridder, D.A. and Schwaninger, M., 2009. NF-kappaB signaling in cerebral ischemia . Neuroscience, 158 (3), 995–1006.
  • Shafiq, S., et al., 2007. Development and bioavailability assessment of ramiprilnanoemulsion formulation. European journal of pharmaceutics and biopharmaceutics, 66 (2), 227–243.
  • Sharma, N., et al., 2018. Development and gamma scintigraphy study of Trigonellafoenum graecum (Fenugreek) polysaccharide-based colon tablet. AAPSPharmSciTech, 19 (6), 2564–2571.
  • Shi, Y., et al., 2015. Development optimization and evaluation of emodin loaded nanoemulsion prepared by ultrasonic emulsification. Journal of drug delivery science and technology, 27, 46–55.
  • Silva, H.D., et al., 2012. Nanoemulsions for food applications: development and characterization. Food and bioprocess technology, 5 (3), 854–867.
  • Thakkar, H.P., et al., 2015. Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability. Journal of microencapsulation, 32 (6), 559–569.
  • Tran, T.H., et al., 2014. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability. Journal of pharmaceutical sciences, 103 (3), 840–852.
  • Vyas, T., et al., 2005. Intranasal drug delivery for brain targeting. Current drug delivery, 2 (2), 165–175.
  • Wei, Z.N. and Kuang, J.G., 2018. Vitamin D deficiency in relation to the poor functional outcomes in nondiabetic patients with ischemic stroke. Bioscience reports, 38 (2), 1–32.
  • Yu, H.L., et al., 2019. ESE1 expression correlates with neuronal apoptosis in the hippocampus after cerebralischemia/reperfusion injury. Neural regeneration research, 14 (5), 841–849.
  • Zhou, R., et al., 2018. Lower vitamin D status is associated with an increased risk of ischemic stroke: a systematic review and meta-analysis. Nutrients, 10 (3), 277.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.